Seer, Inc.

Biotechnology • Healthcare • Redwood City, CA, United States • SEER (NMS)

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

650 453 0000 3800 Bridge Parkway, Redwood City, CA 94065, United States

Stock Performance (90 Days)

Data through Dec 30, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Owning 41% shares,institutional owners seem interested in Seer, Inc. (NASDAQ:SEER), - Yahoo Finance

Yahoo Finance • Sep 19

Seer, Inc. Publishes Landmark Genome-Wide Association Study Validating Mass Spectrometry Proteomics in Nature Genetics | SEER Stock News - Quiver Quantitative

Quiver Quantitative • Dec 1

Seer (NASDAQ: SEER) ends dual-class shares as Class B converts to Class A - Stock Titan

Stock Titan • Dec 12

Seer (NASDAQ:SEER) Shares Down 2.8% - Here's What Happened - MarketBeat

MarketBeat • Dec 13

Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook - GlobeNewswire

GlobeNewswire • Aug 6

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Seer, Inc. had layoffs?

No layoff events have been recorded for Seer, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Seer, Inc. have?

Seer, Inc. has approximately 134 employees.

What industry is Seer, Inc. in?

Seer, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Seer, Inc. a publicly traded company?

Yes, Seer, Inc. is publicly traded under the ticker symbol SEER on the NMS. The company has a market capitalization of approximately $0.10 billion.

Where is Seer, Inc. headquartered?

Seer, Inc. is headquartered in Redwood City, CA, United States at 3800 Bridge Parkway, Redwood City, CA 94065, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.